# ARCH CAPITAL GROUP LTD. (ACGLO) — Financial Analysis

**Exchange:** Nasdaq  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-03  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/ACGLO/thesis · /stocks/ACGLO/memo

## Financial Snapshot

---
source: coverage-next-full
step: "04"
title: Financial Quality & Adversarial Sweep
ticker: ACGLO
company: Arch Capital Group Ltd.
date: 2026-06-03
---

### Step 04 — Financial Quality & Adversarial Research Sweep: Arch Capital Group Ltd. (ACGL / ACGLO)

#### 1. Financial Statement Quality Assessment

##### Statement-of-Operations Quality

**Revenue recognition:** Premiums are earned on a pro-rata basis over the policy period — conservative, well-understood, and auditor-verified. No aggressive accelerations. Net realized gains/losses are volatile but disclosed separately and flagged by management as non-operating. Investment income is straightforward: yield × average invested assets. [S1]

**Loss reserves:** The most significant accounting judgment. Arch carries approximately $18-22B in total loss and LAE reserves (estimate; Arch reports gross reserves in segment detail). Reserve adequacy is:
- Confirmed by annual actuarial certification (per statutory requirements)
- Tested in Note disclosures (prior-year development tables)
- Benchmarked by ratings agencies (AA- from S&P — reflects confidence in reserving)
- Supported by Arch's consistent prior-year favorable reserve development record (no material adverse development in 2020–2024 period per 10-K disclosures) [S2]

**Acquisition costs (DAC):** Deferred over policy period — standard. Amortization ratio of 17.6% (FY2024) is stable and in-line with industry (slightly below average, reflecting Arch's mix of wholesale/excess-of-loss business where acquisition costs are lower). [S1]

**Investment portfolio:** 90%+ investment-grade fixed income. Mark-to-market losses in 2022 were unrealized (AOCI); not recognized through the income statement. Conservative. [S1]

##### Balance Sheet Quality

**Assets:** Dominated by invested assets ($40.5B, 57% of total assets). Reinsurance recoverables ($7-10B estimated — recoveries from ceded reinsurance programs) require credit assessment. Arch's diversified retrocession panel (with highly-rated counterparties) limits credit exposure. No evidence of concentrated counterparty risk in disclosures.

**Liabilities:** Unpaid premiums, losses, and LAE are the primary liabilities. These are estimated; see reserve quality above. Debt at $2.73B senior notes is modest relative to equity ($20.8B). No off-balance-sheet financing structures identified. [S2]

**Equity:** AOCI (accumulated other comprehensive income) includes unrealized gains/losses on fixed income portfolio. 2022 saw AOCI drawdown as rates rose; normalized as rates stabilized in 2023-2024. BVPS excluding AOCI fluctuations still grew consistently.

##### Cash Flow Quality

Operating cash flow: $6.7B (FY2024). This represents 155% of net income — abnormally high due to the premium-collected-in-advance nature of insurance accounting (premiums received before coverage exhausted). This is normal and healthy for an insurer; it confirms the business is not consuming cash to support earnings. [S1]

**Red flags checked:**
- Divergence between net income and operating cash flow: None (positive divergence expected and present)
- Working capital deterioration: N/A for insurance (premiums-in-advance business)
- Goodwill: Modest from historical acquisitions (Watford Holdings 2021, others); no impairment charges
- Off-balance-sheet obligations: None material identified in 10-K disclosures

#### 2. Key Ratio Analysis

##### Profitability

| Metric | FY2022 | FY2023 | FY2024 |
|--------|--------|--------|--------|
| Loss Ratio (NPE basis) | 51.9% | 50.2% | 55.2% |
| Expense Ratio (est.) | 27-29% | 27-29% | ~27% |
| Combined Ratio (P&C, est.) | ~79-80% | ~77-79% | ~82-84% |
| Operating ROAE | ~14-15% | 21.6% | 18.9% |
| Net Income ROE | ~11.4% | 24.2% | 20.7% |
| NII / Average Investments | ~1.7% | 3.0% | 3.7% |

##### Balance Sheet

| Metric | FY2022 | FY2023 | FY2024 |
|--------|--------|--------|--------|
| Total Assets ($B) | $48.0 | $58.9 | $70.9 |
| Book Value Per Share ($) | $34.85 | $49.15 | $55.31 (BVPS ex-preferred ~$53.11 management) |
| Financial Leverage (Debt/Capital) | ~17% | ~13% | ~12% |
| Net Debt ($B) | $1.87 | $1.81 | $1.75 |

##### Per-Share Metrics

| Metric | FY2022 | FY2023 | FY2024 |
|--------|--------|--------|--------|
| Diluted EPS ($) | $3.80 | $11.62 | $11.19 |
| BVPS ($) | $32.62 | $46.94 | $53.11 |
| BVPS Growth (%) | -8.7% (AOCI drag) | +43.9% | +13.1% |
| OCF Per Share ($) | ~$10.30 | ~$15.40 | ~$17.72 |

#### 3. Adversarial Research Sweep

##### 3a. Short Seller & Negative Reports

**Findings:** No significant short thesis or activist campaign identified against ACGL. The company has not been a target of prominent short sellers (Citron, Muddy Waters, Hindenburg) as of June 2026. Short interest is modest (estimated <2% of float). [S3]

**Why ACGL is not a typical short target:** Bermuda insurers are transparent (SEC-registered, GAAP reporting); reserve quality is externally audited; no complex corporate structure obfuscating cash flows; management has strong credibility track record.

##### 3b. Legal & Regulatory Investigations

**Findings:** No material class action lawsuits, SEC investigations, or regulatory enforcement actions identified in 10-K risk factor disclosures or press searches as of June 2026. [S2]

**Routine litigation:** As a large insurer, Arch is involved in routine coverage disputes and reinsurance arbitration (industry-standard). These are disclosed in 10-K legal proceedings; none appear material.

**OECD Pillar Two:** The one notable "adversarial" accounting item is the Bermuda tax change. FY2023 net income was boosted by a $1.16B one-time deferred tax benefit from the adoption of Bermuda's OECD Pillar Two 15% minimum tax legislation. This one-time gain inflated FY2023 ROE; normalizing for it, FY2023 operating ROAE was ~21.6%. Management and analysts were transparent about this. [S2]

##### 3c. Governance Red Flags

**CEO transition:** Marc Grandisson (founder-era CEO) retired October 2024. Nicolas Papadopoulo, long-tenured Arch executive (President, Reinsurance), was appointed. This is an internal succession — low risk of cultural or strategic drift. No governance concerns flagged. [S4]

**Compensation structure:** Aligned with underwriting results and ROE; no production volume targets. Executive pay at Arch is considered well-structured by governance analysts. Say-on-pay received 95.3% approval at 2024 AGM. [S4]

**Board independence:** S&P upgrade to AA- in 2024 cited improved governance practices. No related-party transaction concerns identified.

##### 3d. Reserving Risk Assessment

**Key risk:** Insurance reserving is an estimate. Arch's casualty book (both Insurance and Reinsurance segments) is exposed to long-tail social inflation risk — the same risk that caused Everest Group to take a $1B+ reserve charge in FY2024.

**Arch's record:** Arch has NOT taken material adverse reserve development in the 2020–2024 period, unlike Everest Group, Hartford (reserve issues in casualty), or other peers. This reflects:
1. Conservative initial reserving (above-median actuarial selections)
2. Mix toward shorter-tail lines (property) in the reinsurance book
3. Disciplined underwriting with no production pressure

**Risk remains:** Arch is not immune. If social inflation accelerates further in US casualty lines, adverse development is possible. Watching for disclosure of any adverse prior-year development in future 10-Qs. [S2]

##### 3e. Catastrophe Accumulation Risk

**FY2024 events:** Hurricane Helene and Hurricane Milton drove ~$393M pre-tax cat losses. This was within Arch's publicly stated catastrophe risk appetite and did not impair capital significantly.

**California wildfires (Jan 2025):** Arch likely had moderate exposure (consistent with its book composition). No material loss announcement in Q1 2026 results — appears to have been manageable. [S3]

**Risk:** A major capital-market disrupting event (10-year+ return period) could temporarily impair BVPS and require equity issuance. This risk is inherent to the business model and is what creates the pricing cycle that Arch exploits.

#### 4. Financial Quality Verdict

| Dimension | Score | Notes |
|-----------|-------|-------|
| Revenue quality | ★★★★★ | Earned premiums + investment income; predictable |
| Reserving quality | ★★★★☆ | Strong track record; long-tail social inflation risk |
| Balance sheet quality | ★★★★★ | Conservative leverage; investment-grade assets |
| Cash flow quality | ★★★★★ | OCF >> net income; cash-generative model |
| Management integrity | ★★★★★ | No fraud red flags; aligned compensation |
| Accounting quality | ★★★★★ | Standard GAAP; no complex structures |
| **Overall** | **★★★★☆ (4.8/5)** | Best-in-class; only note is inherent cat and reserving tail risk |

*Thesis updated: Financial quality high; no adversarial red flags. Primary risk to thesis is reserving adequacy in casualty lines — monitoring for adverse development.*

#### Source Index

| ID | Source |
|----|--------|
| S1 | SEC EDGAR XBRL Company Facts + StockAnalysis financial data, CIK0000947484 |
| S2 | Arch Capital Group 10-K FY2024, Notes to Financial Statements and MD&A |
| S3 | Consensus.md; press search (MarketBeat, GuruFocus, Benzinga); no short thesis found |
| S4 | Arch Capital proxy 2024; governance_and_compensation.md |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/ACGLO/fundamental

## Navigation

- Overview: /stocks/ACGLO
- Financials (this page): /stocks/ACGLO/financials
- Thesis: /stocks/ACGLO/thesis
- Investment Memo: /stocks/ACGLO/memo
- Coverage universe: /stocks